Lung Function Course of Patients With Pulmonary Fibrosis After Initiation of Anti‐Fibrotic Treatment: Real‐World Data From the Dutch National Registry
The FVC decline significantly slowed after the initiation of treatment for both IPF and PPF. Nevertheless, a significant proportion of patients exhibited disease progression, despite the start of anti-fibrotic treatment. Early identification of these patients is crucial for treatment adaptations and inclusion in clinical trials.
Authors
- Mark G. J. P. Platenburg (ORCID: https://orcid.org/0000-0001-5541-5092)
- Gizal Nakshbandi
- B.A.H.A. Bogaarts
- Rémy L.M. Mostard (ORCID: https://orcid.org/0000-0002-0127-2855)
- Linda Moonen
- E.R. Marges (ORCID: https://orcid.org/0000-0003-1829-533X)
- Paul Bresser (ORCID: https://orcid.org/0000-0002-0839-6770)
- Marlies Wijsenbeek (ORCID: https://orcid.org/0000-0002-4527-6962)
- Eveline Schakenraad
- Aernoud A. van Batenburg (ORCID: https://orcid.org/0000-0002-2841-7911)
- Stefan Walen (ORCID: https://orcid.org/0000-0001-6563-1119)
- H. Krämer (ORCID: https://orcid.org/0000-0002-3785-0258)
- N Hekelaar
- Jan C. Grutters (ORCID: https://orcid.org/0000-0003-3670-8097)
- Catharina C. Moor (ORCID: https://orcid.org/0000-0002-5295-2877)
- Jan van der Maten
- Bart B. Boerrigter
- Mareye Voortman (ORCID: https://orcid.org/0000-0001-8215-6794)
- Pedro Miranda Afonso (ORCID: https://orcid.org/0000-0001-6708-9597)
- Maria J. Overbeek
- C. A. van der Sloot
Institutions
- Leiden University (NL)
- Radboud University Nijmegen (NL)
- Leiden University Medical Center (NL)
- Maastricht University Medical Centre (NL)
- Catharina Ziekenhuis (NL)
- Medisch Spectrum Twente (NL)
- Medisch Centrum Leeuwarden (NL)
- University Medical Center Utrecht (NL)
- Medisch Centrum Haaglanden (NL)
- St. Antonius Ziekenhuis (NL)
- OLVG (NL)
- Martini Ziekenhuis (NL)
- VieCuri Medisch Centrum (NL)
- Zuyderland Medisch Centrum (NL)
- Isala (NL)
- Rijnstate Hospital (NL)
- Jeroen Bosch Ziekenhuis (NL)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- Respirology
- Published
- 2025-03-23
- DOI
- https://doi.org/10.1111/resp.70030
- Citations
- 4
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 6.07
Funders
- Boehringer Ingelheim